The assembly conformation of rotavirus VP6 determines its protective efficacy against rotavirus challenge in mice


Por: Pastor A.R., Rodríguez-Limas W.A., Contreras M.A., Esquivel E., Esquivel-Guadarrama F., Ramírez O.T., Palomares L.A.

Publicada: 19 may 2014
Resumen:
Viral protein assemblies have shown to be superior immunogens used in commercial vaccines. However, little is known about the effect of protein assembly structure in immunogenicity and the protection conferred by a vaccine. In this work, rotavirus VP6, a polymorphic protein that assembles into nanotubes, icosahedra (dlRLP) or trimers was used to compare the immune response elicited by three different assemblies. VP6 is the most antigenic and abundant rotavirus structural protein. It has been demonstrated that antibodies against VP6 interfere with the replication cycle of rotavirus, making it a vaccine candidate. Groups of mice were immunized with either nanotubes, dlRLP or trimers and the humoral response (IgG and IgA titers) was measured. Immunized mice were challenged with EDIM rotavirus and protection against rotavirus infection, measured as viral shedding, was evaluated. Immunization with nanotubes resulted in the highest IgG titers, followed by immunization with dlRLP. While immunization with one dose of nanotubes was sufficient to reduce viral shedding by 70%, two doses of dlRLP or trimers were required to obtain a similar protection. The results show that the type of assembly of VP6 results in different humoral responses and protection efficacies against challenge with live virus. This information is important for the design of recombinant vaccines in general. (C) 2014 Elsevier Ltd. All rights reserved.

Filiaciones:
Pastor A.R.:
 Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico

Rodríguez-Limas W.A.:
 Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico

Contreras M.A.:
 Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico

Esquivel E.:
 Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico

Esquivel-Guadarrama F.:
 Facultad de Medicina, Universidad Autónoma Del Estado de Morelos, Cuernavaca, Morelos, Mexico

Ramírez O.T.:
 Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico

Palomares L.A.:
 Univ Nacl Autonoma Mexico, Inst Biotechnol, Dept Med Mol & Bioproc, Cuernavaca 62210, Morelos, Mexico
ISSN: 0264410X
Editorial
ELSEVIER SCI LTD, THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND, Países Bajos
Tipo de documento: Article
Volumen: 32 Número: 24
Páginas: 2874-2877
WOS Id: 000336704900019
ID de PubMed: 24583002